Research Field

Research Field Biomedical engineering

Building the Human Genome

| William Aryitey

An ambitious, large-scale project plans to fully construct a synthetic human genome

Research Field Genetics

A Genetic Basis for MS

| William Aryitey

The discovery of multiple sclerosis' genetic origin may lead to better therapies

Research Field Biomedical engineering

Rise of the Pigoons

| Charlotte Barker

Fiction becomes reality as scientists plan to grow human organs inside pigs

Research Field Genetics

Ghost in the Cell

| William Aryitey

New software couples computer programming with cell function using the ultimate coding language: DNA

Research Field Drug discovery

Arresting ALS

| Joe Beckman

When it comes to prognosis, the mouse models I use to study amyotrophic lateral sclerosis (ALS) are sadly accurate – like their human counterparts with familial ALS, all mice with these mutations die young. After 20 years of trying – and failing – to find a treatment that could extend life, I was close to giving up, until a new drug candidate came along. Then something amazing happened – a mouse lived.

Research Field Biomedical engineering

Image of the Month

| Charlotte Barker

Azad Shademan and Ryan Decker during supervised autonomous in vivo bowel anastomosis.

Research Field Cancer

Cancer Static Shock

| James Strachan

Are the metrics used to measure cancer drug efficacy inherently flawed?

Research Field Biomedical engineering

Bioprinting in the Palm of Your Hand

| William Aryitey

BioPen could allow surgeons to “draw” live cells onto damaged bone

Research Field Biomedical engineering

Mind Over Matter

| William Aryitey

Neural implants and smart software give a paralyzed patient the gift of movement

Research Field Immunology

Mucky Pups

| William Aryitey

New findings have revealed that “dirty” mice can actually recapitulate the human adult immune system better than lab mice

Register to The Translational Scientist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts

Register